期刊文献+

两种关键信号转导通路活性状态与K562细胞对DNR、Ara-C敏感性的关系

Research for sensitivity of K562 cell line to the chemotherapeutic drugs under two key signal transduction pathways of different activity status
下载PDF
导出
摘要 目的观察两种关键信号转导通路的活性状态与白血病细胞株K562对柔红霉素(DNR)、阿糖胞苷(Ara-C)的敏感性的关系。方法将K562细胞分为5个组,经U0126、LY294002、雷帕霉素处理的细胞分别为抑制剂A、B、C组,经佛波酯(PMA)刺激的细胞为激活剂组,未作处理者为对照组。采用磷酸化流式细胞术检测细胞中的p-Akt T308、p-Akt S473及p-ERK1/2。将各组细胞分别与DNR、Ara-C作用48 h,采用AnnexinⅤ/PI标记法检测细胞凋亡率。结果抑制剂A组p-ERK1/2表达及抑制剂B组p-ERK1/2、p-Akt T308、p-Akt S473表达均低于对照组(P均<0.05);激活剂组p-ERK1/2、p-Akt S473表达高于对照组(P均<0.05);抑制剂C组p-ERK1/2、p-AktT308、p-Akt S473表达及激活剂组p-Akt T308与对照组相近(P均>0.05)。DNR和Ara-C作用后激活剂组细胞凋亡率均低于对照组(P均<0.05)。DNR作用后,抑制剂A、B、C组细胞凋亡率均高于对照组(P均<0.05);Ara-C作用后,抑制剂B、C组的细胞凋亡率高于对照组(P均<0.05),抑制剂A组与对照组凋亡率无显著差异(P>0.05)。结论在信号转导通路激活状态下,K562对DNR、Ara-C的敏感性降低,抑制Ras/PI3K/PTEN/Akt/mTOR通路能增强K562对DNR、Ara-C的敏感性,Ras/Raf/MEK/ERK通路激活可能与DNR耐药有关,但抑制该通路对Ara-C诱导的K562细胞凋亡无直接作用。 Objective To observe the sensivity of K562 cell lines to DNR and Ara-C under two key signal transduction pathways of different activity status. Methods K562 cells were divided into five groups. Inhibitor groups A, B, C were treated with U0126, LY294002, rapamycin, respectively. Activator group was treated with phorbol (PMA). Cells without any stimulate considered as control group. Adapt phospho-specific flow cytometry to analyse the expression of Akt T308 ,Akt $473 and ERK1/2. Each group of cells incubated with DNR and Ara-C respectively for 48 hours. The apoptosis rate of K562 cells were detected by Annexin V/PI. Expression of p-ERK1/2 of group A and p-ERK1/2 ,p-Akt T308, p-Akt $473 of group B were lower than control group( all P 〈 0.05 ). The expression of p-ERK1/2, p-Akt $473 of activator group were higher than control group( all P 〈 0.05 ). The expression of p-ERK1/2, p-Akt T308, p-Akt $473 of group C and p-Akt T308 of activator group were close to control group( all P 〉 0.05 ). The apoptosis rate of activator group induced by DNR and Ara-C were lower than control group (all P 〉 0.05 ). The apoptosis rate of group A, B, C induced by DNR were higher than control group( all P 〈 0.05 ). The apoptosis rate of group B, C induced by Ara-C were higher than control group( all P 〈 0.05 ). The apoptosis rate of group A induced by Ara-C has no different with control group( P 〉 0.05 ). Conclutions The activate of signal transduction pathways can reduce the sensitivity of K562 cells to DNR and Ara-C. Ras/Raf/MEK/ ERK pathways may correlated with resistanceto DNR, but inhibit this pathways has no direct relation to the apoptosis in- duced by Ara-C.
出处 《山东医药》 CAS 2012年第30期19-21,共3页 Shandong Medical Journal
关键词 信号转导通路 磷酸化信号蛋白 药物疗法 柔红霉素 阿糖胞苷 细胞凋亡 白血病 signal transduction pathways phospho-siganling proteins drugs therapy daunorubicin cytarabine ap-optosis leukemia
  • 相关文献

参考文献13

  • 1McCubrey JA, Abrams SL, Ligresti G, et al. Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance [ J]. Leukemia, 2008, 22 ( 11 ) :2080-2090.
  • 2Irish JM, Koteeha N, Nolan GP. Mapping normal and cancer cell signalling net- works: towards single-cell proteomies [ J ]. Nat Rev Cancer, 2006,6(2) :146-155.
  • 3Gallay N, Santos CD, Cuzin L. The level 8f AKT phosphorylatian on threonine 308 but not on serine 473 is associated with high-risk eytogenetics and predicts poor overall survival in acute myeloid leu- kaemia[J]. Leukemia, 2009,23(6) : 1029-1038.
  • 4梁爱斌 ,李莉 ,谢晓恬 ,江华 ,叶辉 ,赵金彩 ,GU Long-jun .不同危险分组ALL细胞PI3K/AKT磷酸化激活的初步研究[J].同济大学学报(医学版),2005,26(1):52-55. 被引量:2
  • 5Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy [ J ]. Cell Signal, 2002, 14 ( 5 ) : 381-395.
  • 6Stephen L. The Raf/MEK/ERK pathway can govern drug resist- ance, apoptosis and sensitivity to targeted therapy[ J]. Cell Cycle, 2010,9(9) :1781-1791.
  • 7Noor SM, Bell M. Shooting the messenger: Targeting signal trans- duction pathways in leukemia and related disorders [ J ]. Crit Rev in Oncol/Hematol, 2011,78( 1 ) :33-44.
  • 8McCubrey JA, Steelman LS, Abrams SL, et al. Emerging Raf In- hibitors[ J]. Exp Opin Emerging Drugs, 2009, 14(4) :633-648.
  • 9Martelli AM, Evangelisti C, Chiarini F, et al. The emerging role of the phosphatiylinositol 3 kinase/Akt/mammalian target of rapam- ycin signaling network in normal myelopoiesis and leukemogensis [J]. Biochim Biophys Act, 2010, 1803(9) :991-1002.
  • 10Steelman IS, Chappell WH, Abram SL. Roles of the Raf/MEK/ ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy- implications for cancer and aging [J]. Aging, 2011,3 (3) : 192-222.

二级参考文献9

  • 1Giomore AP, Valentijn AJ, Wang P, et al. Activation of Bad by therapeutic inhibition of epidermal growth factor receptor and transaction by insulin-like growth factor receptor[J]. J Biol Chem,2002,277(31) :27643 - 27650.
  • 2Testa JR, Ballacosa A. AKT plays a central role in tumorigenesis[J]. Proc Natl Acad Sci USA, 2001, 98 (20):10983 - 10985.
  • 3Colby-Graham MF, Chordas C. The childhood leukemias [J]. J Pediatr Nurs,2003, (18): 87 - 95.
  • 4Pui CH, Relling MV, Campana D, et al. Childhood acute lymphoblastic leukemia[J]. Rev Clin Exp Hematol, 2002,6(2) :161-80.
  • 5Xu Q Simpson, S E Scialla, T J Bagg, et al. Survival of acute myeloid leukemia cells requires PI3 kinase activation [J]. Blood,2003,102(3) :972 - 980.
  • 6West K A, Castillo SS, Dennis PA. Activation of the PI3K/Akt pathway and chemotherapeutic resistance[J].Drug resistance updates, 2002,5 (3): 234 - 248.
  • 7Damu T, Hitoshi Okada, Jurgen Ruland, et al. Akt is activated in response to an apoptosis signal[J]. J Biol Chem,2001,276(32) :30461 - 30466.
  • 8Ng SSW, Tsao MS, Nicklee T, et al. Wortmannin inhibits PKB/Akt phosphorylation and promotes gemcitabine-induced apoptosis in human pancreatic cancer cells[J]. Cancer research, 2001,7 (10): 3269 - 3275.
  • 9Jones RG,Parsons M,Bonnard M, et al.PKB regulates T lymphocyte survival,nuclear factor kB activation,and BclXL levels in vivo[J].J exp Med,2000,15(191):1721-1734.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部